Our Q3 2025 results will be published on November 13, 2025, at 7 a.m. (CET). Our conference call for the media will take place at 09:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Investors
Welcome to our Investor Relations
Here you’ll find everything you might be interested in if you want to invest in vibrant science and technology.
-
5 reasons to invest
We develop products and solutions that make life better – and have been successfully doing so for more than 350 years. And when you’ve prospered for centuries as we have, you must have done a few things right.Read More -
Sustainability
For us, scientific progress and responsible entrepreneurship go hand in hand, enabling us to create a sustainable future for everyoneRead more -
Reports & Financials
Merck KGaA, Darmstadt, Germany, keeps growing profitably. The excellent performance of our business shows that we are on the right track. See for yourself in our comprehensive reports and financials.Read More
Upcoming Event
View All EventsInvestor Related News
View All News-
Press Releases
Launch of EdiMembre to Transform Alternative Protein Industry
Together with mantro GmbH we have established EdiMembre, Inc., Massachusetts, U.S.A., a Deep Tech spin-out in the alternative protein industry.
2025/08/18
-
Press Releases
European Commission Grants Approval of Ogsiveo
The European Commission granted approval for Ogsiveo for the treatment of adults with desmoid tumors.
2025/08/18
-
Press Releases
Q2 2025: Merck KGaA, Darmstadt, Germany, Delivers Profitable Organic Growth ...
Strong sales in Process Solutions and for blockbusters Mavenclad and Erbitux, sustained demand for Semiconductor Materials.
2025/08/07
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price

Capital Market Days
Learn MoreCapital Market Days


Webcasts & Presentations
Learn MoreWebcasts & Presentations


Annual General Meeting
Learn MoreAnnual General Meeting
Get in touch!
We're here to help. Get in touch if you have any questions.
+49 6151 72 91 3321